7 Things to Know About the Upcoming IsoPlexis (ISO) IPO

October 4, 2021 10:59 AM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

IsoPlexis Corporation's (NYSE: ISO), which sells single-cell analysis platform to researchers around the globe, stock is due to go public later this week. Here are 7 key things to know about the upcoming IsoPlexis IPO.

1) IsoPlexis IPO Date - Isoplex is due to go public on October 08. Isoplex will start trading under the ticker symbol “ISO” on the Nasdaq stock exchange. Generally, shares that make their public stock market debuts start trading between 10 AM - 2 PM ET.

2) IsoPlexis IPO Pricing - Isoplex is expected to price its shares between $14.00 and $16.00.

3) Shares Offered - Isoplex is seeking to sell 8,330,000 shares of its common stock. The S-1 filing shows the number of outstanding shares after IPO offering would be 38,844,251 shares (or 40,094,201 shares if the underwriters exercise in full).

4) IsoPlexis IPO Valuation - Isoplex is seeking a valuation of between $543.8 million and $621.5 million.

5) IsoPlexis IPO Raised Proceeds: At the midpoint of the pricing range, ISO is looking to raise $133.8 million. Isoplex plans to use the raised proceeds for general business purposes.

6) IsoPlexis IPO Underwriters - Morgan Stanley, Cowen, Evercore ISI, and SVB Leerink are underwriters for the IPO.

7) ISO Financials - Isoplex reported it sold 150 single-cell analysts systems worldwide as of June 30 this year. Revenue for the first six months of the year was $7.5 million, more than double compared to $3.7 million in the same period last year. The company generated a net loss of $36.1 million in H1 2021.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

IPOs, Insiders' Blog

Related Entities

Morgan Stanley, Cowen & Co, S1, IPO